Market Overview

Benzinga's Top Upgrades, Downgrades For July 7, 2020

Share:

Upgrades

  • UBS upgraded the stock for OGE Energy Corp (NYSE: OGE) from Neutral to Buy. In the first quarter, OGE Energy showed an EPS of $0.23, compared to $0.24 from the year-ago quarter. The stock has a 52-week-high of $46.43 and a 52-week-low of $23.00. OGE Energy's stock last closed at $30.50 per share.
  • Wedbush changed the rating for Unum Therapeutics Inc (NASDAQ: UMRX) from Neutral to Outperform. Unum Therapeutics earned ($0.20) in the first quarter, compared to ($0.39) in the year-ago quarter. The stock has a 52-week-high of $2.84 and a 52-week-low of $0.29. Unum Therapeutics's stock last closed at $2.20 per share.
  • Needham upgraded the stock for Ambarella Inc (NASDAQ: AMBA) from Underperform to Buy. For the first quarter, Ambarella had an EPS of $0.04, compared to year-ago quarter EPS of $0.01. The stock has a 52-week-high of $73.59 and a 52-week-low of $36.02. Ambarella's stock last closed at $46.79 per share.
  • For ACADIA Pharmaceuticals Inc (NASDAQ: ACAD), Stifel upgraded the stock from Hold to Buy. In the first quarter, ACADIA Pharmaceuticals showed an EPS of ($0.57), compared to ($0.59) from the year-ago quarter. The stock has a 52-week-high of $53.80 and a 52-week-low of $21.56. ACADIA Pharmaceuticals's stock last closed at $53.69 per share.
  • Deutsche Bank upgraded the stock for Arthur J. Gallagher & Co (NYSE: AJG) from Hold to Buy. In the first quarter, Arthur J. Gallagher showed an EPS of $1.83, compared to $1.63 from the year-ago quarter. The stock has a 52-week-high of $109.46 and a 52-week-low of $65.09. Arthur J. Gallagher's stock last closed at $96.85 per share.
  • For Trex Co Inc (NYSE: TREX), Baird upgraded the stock from Neutral to Outperform. In the first quarter, Trex Co showed an EPS of $0.73, compared to $0.54 from the year-ago quarter. The stock has a 52-week-high of $132.84 and a 52-week-low of $56.22. Trex Co's stock last closed at $126.61 per share.
  • For Valmont Industries Inc (NYSE: VMI), Stifel upgraded the stock from Hold to Buy. For the first quarter, Valmont Industries had an EPS of $1.99, compared to year-ago quarter EPS of $1.84. The stock has a 52-week-high of $154.86 and a 52-week-low of $82.60. Valmont Industries's stock last closed at $113.83 per share.

 

Downgrades

  • Benchmark changed the rating for ACM Research Inc (NASDAQ: ACMR) from Buy to Hold. In the first quarter, ACM Research showed an EPS of $0.11, compared to $0.14 from the year-ago quarter. The stock has a 52-week-high of $83.80 and a 52-week-low of $12.51. ACM Research's stock last closed at $80.84 per share.
  • Guggenheim downgraded the stock for BELLUS Health Inc (NASDAQ: BLU) from Buy to Neutral. For the first quarter, BELLUS Health had an EPS of ($0.18), compared to year-ago quarter EPS of ($0.08). The stock has a 52-week-high of $12.03 and a 52-week-low of $2.52. BELLUS Health's stock last closed at $3.40 per share.
  • Ladenburg Thalmann downgraded the stock for Digital Turbine Inc (NASDAQ: APPS) from Buy to Neutral. Digital Turbine earned $0.05 in the fourth quarter, compared to $0.03 in the year-ago quarter. The stock has a 52-week-high of $13.96 and a 52-week-low of $3.48. Digital Turbine's stock last closed at $13.43 per share.
  • For Evolus Inc (NASDAQ: EOLS), Mizuho downgraded the stock from Buy to Neutral. Evolus earned ($0.59) in the first quarter, compared to ($0.83) in the year-ago quarter. The stock has a 52-week-high of $20.27 and a 52-week-low of $3.12. Evolus's stock last closed at $5.32 per share.
  • Guggenheim changed the rating for Illumina Inc (NASDAQ: ILMN) from Buy to Neutral. For the first quarter, Illumina had an EPS of $1.64, compared to year-ago quarter EPS of $1.60. The stock has a 52-week-high of $384.21 and a 52-week-low of $196.78. Illumina's stock last closed at $379.39 per share.
  • JP Morgan downgraded the stock for Cosan Ltd (NYSE: CZZ) from Overweight to Neutral. Cosan earned $0.66 in the first quarter. The stock has a 52-week-high of $23.70 and a 52-week-low of $8.56. Cosan's stock last closed at $17.81 per share.
  • For Dominion Energy Inc (NYSE: D), Mizuho downgraded the stock from Neutral to Underperform. For the first quarter, Dominion Energy had an EPS of $1.09, compared to year-ago quarter EPS of $1.10. The stock has a 52-week-high of $90.89 and a 52-week-low of $57.79. Dominion Energy's stock last closed at $73.59 per share.
  • JP Morgan downgraded the stock for Fortinet Inc (NASDAQ: FTNT) from Overweight to Neutral. In the first quarter, Fortinet showed an EPS of $0.60, compared to $0.46 from the year-ago quarter. The stock has a 52-week-high of $149.69 and a 52-week-low of $70.20. Fortinet's stock last closed at $139.70 per share.
  • Goldman Sachs downgraded the stock for Kinder Morgan Inc (NYSE: KMI) from Neutral to Sell. For the first quarter, Kinder Morgan had an EPS of $0.24, compared to year-ago quarter EPS of $0.25. The stock has a 52-week-high of $22.58 and a 52-week-low of $9.42. Kinder Morgan's stock last closed at $15.20 per share.
  • BMO Capital changed the rating for ObsEva SA (NASDAQ: OBSV) from Outperform to Market Perform. For the first quarter, ObsEva had an EPS of ($0.48), compared to year-ago quarter EPS of ($0.59). The stock has a 52-week-high of $11.28 and a 52-week-low of $1.63. ObsEva's stock last closed at $3.25 per share.
  • JP Morgan changed the rating for Moelis & Co (NYSE: MC) from Neutral to Underweight. In the first quarter, Moelis & Co showed an EPS of $0.27, compared to $0.27 from the year-ago quarter. The stock has a 52-week-high of $41.27 and a 52-week-low of $22.11. Moelis & Co's stock last closed at $31.45 per share.
  • For First Hawaiian Inc (NASDAQ: FHB), Wells Fargo downgraded the stock from Equal-Weight to Underweight. For the first quarter, First Hawaiian had an EPS of $0.30, compared to year-ago quarter EPS of $0.53. The stock has a 52-week-high of $31.25 and a 52-week-low of $13.55. First Hawaiian's stock last closed at $16.74 per share.
  • JMP Securities downgraded the stock for Vivint Solar Inc (NYSE: VSLR) from Market Outperform to Market Perform. In the first quarter, Vivint Solar showed an EPS of ($0.32), compared to ($0.22) from the year-ago quarter. The stock has a 52-week-high of $12.99 and a 52-week-low of $3.17. Vivint Solar's stock last closed at $10.63 per share.
  • For CommScope Holding Co Inc (NASDAQ: COMM), Raymond James downgraded the stock from Outperform to Market Perform. In the first quarter, CommScope Hldg Co showed an EPS of $0.12, compared to $0.48 from the year-ago quarter. The stock has a 52-week-high of $15.93 and a 52-week-low of $5.50. CommScope Hldg Co's stock last closed at $8.68 per share.

 

Initiations

  • With a rating of Buy, Deutsche Bank initiated coverage on The AZEK Co Inc (NYSE: AZEK). The price target is set at $35.00 for AZEK Co.
  • Cowen & Co. initiated coverage on Burning Rock Biotech Ltd (NASDAQ: BNR) with an Outperform rating.
  • Benchmark initiated coverage on Cinedigm Corp (NASDAQ: CIDM) with a Speculative Buy rating. The price target for Cinedigm is set at $3.50. Cinedigm earned ($0.08) in the fourth quarter, compared to ($0.17) in the year-ago quarter. The stock has a 52-week-high of $6.00 and a 52-week-low of $0.25. Cinedigm's stock last closed at $2.08 per share.
  • Wedbush initiated coverage on Generation Bio Co (NASDAQ: GBIO) with an Outperform rating. The price target for Generation Bio is set at $31.00.
  • With a rating of Buy, Seaport Global initiated coverage on Hexcel Corp (NYSE: HXL). The price target is set at $52.00 for Hexcel. Hexcel earned $0.64 in the first quarter, compared to $0.84 in the year-ago quarter. The stock has a 52-week-high of $87.00 and a 52-week-low of $24.54. Hexcel's stock last closed at $45.11 per share.
  • Credit Suisse initiated coverage on Kura Oncology Inc (NASDAQ: KURA) with an Outperform rating. The price target for Kura Oncology is set at $27.00. For the first quarter, Kura Oncology had an EPS of ($0.42), compared to year-ago quarter EPS of ($0.37). The stock has a 52-week-high of $21.42 and a 52-week-low of $6.35. Kura Oncology's stock last closed at $16.72 per share.
  • With a rating of Equal-Weight, Barclays initiated coverage on Pegasystems Inc (NASDAQ: PEGA). The price target is set at $112.00 for Pegasystems. Pegasystems earned $0.05 in the first quarter, compared to ($0.12) in the year-ago quarter. The stock has a 52-week-high of $107.19 and a 52-week-low of $38.01. Pegasystems's stock last closed at $102.50 per share.
  • Citic Securities initiated coverage on Plug Power Inc (NASDAQ: PLUG) with an Overweight rating. The price target for Plug Power is set at $10.69. In the first quarter, Plug Power showed an EPS of ($0.12), compared to ($0.15) from the year-ago quarter. The stock has a 52-week-high of $10.49 and a 52-week-low of $1.88. Plug Power's stock last closed at $9.98 per share.
  • With a rating of Overweight, Barclays initiated coverage on The AZEK Co Inc (NYSE: AZEK). The price target is set at $37.00 for AZEK Co.
  • Stephens & Co. initiated coverage on Cerner Corp (NASDAQ: CERN) with a Equal-Weight rating. The price target for Cerner is set at $75.00. For the first quarter, Cerner had an EPS of $0.71, compared to year-ago quarter EPS of $0.61. The stock has a 52-week-high of $80.90 and a 52-week-low of $53.08. Cerner's stock last closed at $70.93 per share.
  • JP Morgan initiated coverage on Generation Bio Co (NASDAQ: GBIO) with an Overweight rating. The price target for Generation Bio is set at $28.00.
  • Stephens & Co. initiated coverage on IQVIA Holdings Inc (NYSE: IQV) with a Equal-Weight rating. The price target for IQVIA Holdings is set at $150.00. IQVIA Holdings earned $1.50 in the first quarter, compared to $1.53 in the year-ago quarter. The stock has a 52-week-high of $169.14 and a 52-week-low of $81.79. IQVIA Holdings's stock last closed at $143.63 per share.
  • Stephens & Co. initiated coverage on Livongo Health Inc (NASDAQ: LVGO) with an Overweight rating. The price target for Livongo Health is set at $95.00. Livongo Health earned $0.03 in the first quarter. The stock has a 52-week-high of $82.50 and a 52-week-low of $15.12. Livongo Health's stock last closed at $77.63 per share.
  • With a rating of Sector Perform, RBC Capital initiated coverage on Nikola Corp (NASDAQ: NKLA). The price target is set at $46.00 for Nikola. The stock has a 52-week-high of $93.99 and a 52-week-low of $31.25. Nikola's stock last closed at $48.92 per share.
  • Stephens & Co. initiated coverage on Omnicell Inc (NASDAQ: OMCL) with an Overweight rating. The price target for Omnicell is set at $90.00. In the first quarter, Omnicell showed an EPS of $0.66, compared to $0.61 from the year-ago quarter. The stock has a 52-week-high of $94.85 and a 52-week-low of $54.24. Omnicell's stock last closed at $66.76 per share.
  • Piper Sandler initiated coverage on PayPal Holdings Inc (NASDAQ: PYPL) with an Overweight rating. The price target for PayPal Holdings is set at $210.00. PayPal Holdings earned $0.66 in the first quarter, compared to $0.78 in the year-ago quarter. The stock has a 52-week-high of $181.24 and a 52-week-low of $82.07. PayPal Holdings's stock last closed at $176.18 per share.
  • Piper Sandler initiated coverage on Square Inc (NYSE: SQ) with a Neutral rating. The price target for Square is set at $131.00. In the first quarter, Square showed an EPS of ($0.02), compared to $0.11 from the year-ago quarter. The stock has a 52-week-high of $128.36 and a 52-week-low of $32.33. Square's stock last closed at $118.96 per share.
  • Stephens & Co. initiated coverage on Veeva Systems Inc (NYSE: VEEV) with an Overweight rating. The price target for Veeva Systems is set at $290.00. In the first quarter, Veeva Systems showed an EPS of $0.66, compared to $0.50 from the year-ago quarter. The stock has a 52-week-high of $249.51 and a 52-week-low of $118.11. Veeva Systems's stock last closed at $245.50 per share.
  • JP Morgan initiated coverage on Theravance Biopharma Inc (NASDAQ: TBPH) with an Overweight rating. The price target for Theravance Biopharma is set at $29.00. In the first quarter, Theravance Biopharma showed an EPS of ($1.14), compared to ($1.32) from the year-ago quarter. The stock has a 52-week-high of $31.54 and a 52-week-low of $15.72. Theravance Biopharma's stock last closed at $19.94 per share.
  • With a rating of Equal-Weight, Barclays initiated coverage on Trex Co Inc (NYSE: TREX). The price target is set at $134.00 for Trex Co. In the first quarter, Trex Co showed an EPS of $0.73, compared to $0.54 from the year-ago quarter. The stock has a 52-week-high of $132.84 and a 52-week-low of $56.22. Trex Co's stock last closed at $126.61 per share.
  • Chardan Capital initiated coverage on 89bio Inc (NASDAQ: ETNB) with a Buy rating. The price target for 89bio is set at $58.00. 89bio earned ($0.76) in the first quarter, compared to ($7.26) in the year-ago quarter. The stock has a 52-week-high of $47.25 and a 52-week-low of $14.00. 89bio's stock last closed at $26.48 per share.
  • With a rating of Buy, Chardan Capital initiated coverage on Akero Therapeutics Inc (NASDAQ: AKRO). The price target is set at $79.00 for Akero Therapeutics. Interestingly, in the first quarter, Akero Therapeutics's EPS was ($0.42). The stock has a 52-week-high of $35.34 and a 52-week-low of $10.78. Akero Therapeutics's stock last closed at $34.96 per share.
  • With a rating of Buy, Chardan Capital initiated coverage on NGM Biopharmaceuticals Inc (NASDAQ: NGM). The price target is set at $40.00 for NGM Biopharmaceuticals. NGM Biopharmaceuticals earned ($0.28) in the first quarter, compared to ($1.21) in the year-ago quarter. The stock has a 52-week-high of $23.95 and a 52-week-low of $8.81. NGM Biopharmaceuticals's stock last closed at $19.01 per share.
 

Related Articles (ACAD + ACMR)

View Comments and Join the Discussion!

Posted-In: Initiations top upgradesPenny Stocks Upgrades Downgrades Initiation Intraday Update Analyst Ratings

Latest Ratings

StockFirmActionPT
DOWTruist SecuritiesMaintains55.0
SBUXJP MorganMaintains80.0
AAPLCitigroupMaintains125.0
BCDAAlliance Global PartnersInitiates Coverage On11.5
EURNJonesTradingInitiates Coverage On
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com